Nicoletta Lanese

The U.S. Food and Drug Administration (FDA) has approved the first at-home saliva collection test for COVID-19, which people could use to sample their own saliva and send it into a lab for results.

Developed by RUCDR Infinite Biologics, a biorepository based at Rutgers University in New Jersey, the test received “amended emergency use authorization” from the FDA late on May 7, according to a statement from the university. In April, the lab received emergency use authorization for their saliva collection method, which allowed health care workers to begin testing New Jersey residents at select sites throughout the state, The New York Times reported April 29. 



Source link